Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Prostatic Neoplasms Medicine & Life Sciences
Prostatectomy Medicine & Life Sciences
Urinary Bladder Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences
Castration Medicine & Life Sciences
Androgens Medicine & Life Sciences
docetaxel Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2010 2020

Research Output 1996 2019

4 Citations (Scopus)

A phase II trial of the aurora kinase a inhibitor alisertib for patients with castration-resistant and neuroendocrine prostate cancer: Efficacy and biomarkers

Beltran, H., Oromendia, C., Danila, D. C., Montgomery, B., Hoimes, C., Szmulewitz, R. Z., Vaishampayan, U., Armstrong, A. J., Stein, M., Pinski, J., Mosquera, J. M., Sailer, V., Bareja, R., Romanel, A., Gumpeni, N., Sboner, A., Dardenne, E., Puca, L., Prandi, D., Rubin, M. A. & 6 othersScher, H. I., Rickman, D. S., Demichelis, F., Nanus, D. M., Ballman, K. V. & Tagawa, S. T., Jan 1 2019, In : Clinical Cancer Research. 25, 1, p. 43-51 9 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Aurora Kinases
Castration
Tumor Biomarkers
Prostatic Neoplasms
Organoids

AUTHOR REPLY

Farber, N. J., Neylan, C. J., Singer, E. & Elsamra, S. E., Jun 1 2019, In : Urology. 128, p. 29-30 2 p.

Rutgers, The State University

Research output: Contribution to journalComment/debate

Autophagy inhibition to augment mTOR inhibition: A phase I/II trial of everolimus and hydroxychloroquine in patients with previously treated renal cell carcinoma

Haas, N. B., Appleman, L. J., Stein, M., Redlinger, M., Wilks, M., Xu, X., Onorati, A., Kalavacharla, A., Kim, T., Zhen, C. J., Kadri, S., Segal, J. P., Gimotty, P. A., Davis, L. E. & Amaravadi, R. K., Apr 1 2019, In : Clinical Cancer Research. 25, 7, p. 2080-2087 8 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Hydroxychloroquine
Autophagy
Renal Cell Carcinoma
Disease-Free Survival
Everolimus